| |
| Cost-effectiveness of non-invasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C |
| Tsochatzis EA, Crossan C, Longworth L, Gurusamy K, Rodriguez-Peralvarez M, Mantzoukis K, O'Brien J, Thalassinos E, Papastergiou V, Noel-Storr A, Davidson B, Burroughs AK |
|
|
| |
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Tsochatzis EA, Crossan C, Longworth L, Gurusamy K, Rodriguez-Peralvarez M, Mantzoukis K, O'Brien J, Thalassinos E, Papastergiou V, Noel-Storr A, Davidson B, Burroughs AK. Cost-effectiveness of non-invasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C. Hepatology 2014; 60(3): 832-843 Indexing Status Subject indexing assigned by NLM MeSH Antiviral Agents /therapeutic use; Cost-Benefit Analysis; Decision Making; Elasticity Imaging Techniques /economics /methods; Hepatitis C, Chronic /drug therapy /economics /epidemiology; Humans; Liver Cirrhosis /drug therapy /economics /epidemiology; Predictive Value of Tests AccessionNumber 22014029324 Date bibliographic record published 28/08/2014 |
| |
|
|
